SCHEMBL17445340

SCHEMBL17445340

c1ccc(-c2cc(-c3ccccc3)nc(-n3c4ccccc4c4c5c(c6ccccc6c6c5c5ccccc5n6-c5ccccc5)c5ccccc5c43)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 5/20 0.40
KDM4E B2RXH2 2/20 0.40
ATM Q13315 1/20 0.40
KMT2A Q03164 4/20 0.35
MAPT P10636 4/20 0.35
MAPK1 P28482 3/20 0.35
NPSR1 Q6W5P4 2/20 0.35
IL1R1 P14778 1/20 0.35
MEN1 O00255 3/20 0.35
ALDH1A1 P00352 2/20 0.35
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HTT P42858 3/20 0.35
ACHE P22303 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
PTGS2 P35354 1/20 0.33
AGTR1 P30556 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17123117 0.97 L3MBTL1 (0.42) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL23741437 0.95 L3MBTL1 (0.38) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL23741545 0.95 L3MBTL1 (0.38) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL17427663 0.94 L3MBTL1 (0.39) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL17123100 0.94 L3MBTL1 (0.39) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL19998012 0.92 L3MBTL1 (0.40) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL17464054 0.92 L3MBTL1 (0.42) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL17691740 0.91 L3MBTL1 (0.37) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL17445362 0.89 L3MBTL1 (0.42) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL15073908 0.88 L3MBTL1 (0.42) L3MBTL1KDM4EATMKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9780314-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2017-10-03 US disclosed
US-9780314-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2017-10-03 US disclosed
US-20160020408-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2016-01-21 US disclosed
US-20160020408-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2016-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160020408-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF OR51E2, NFE2L2, ORAI2 L3MBTL1 942/4885KDM4E 446/4885ATM 2208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.